AKT1 and prostate carcinoma: 5′-adenosine monophosphate-activated protein kinase (AMPK) is a target phosphorylated by AKT and an upstream regulator of mTOR involved in prostate cancer metabolism, but its impact on cell survival remains complex due to the numerous pathways it interacts with [163].